"10.1371_journal.pone.0152248","plos one","2016-03-31T00:00:00Z","Richard E Nelson; Makoto Jones; Molly Leecaster; Matthew H Samore; William Ray; Angela Huttner; Benedikt Huttner; Karim Khader; Vanessa W Stevens; Dale Gerding; Marin L Schweizer; Michael A Rubin","Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States of America; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States of America; Infection Control Program, Geneva Hospitals, Geneva, Switzerland; Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, United States of America; Edward Hines Jr. VA Hospital, Hines, IL, United States of America; Iowa City Veterans Affairs Health Care System, Iowa City, IA, United States of America; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States of America","Conceived and designed the experiments: RN MJ ML MHS WR AH BH KK VS DG MR. Performed the experiments: RN MJ WR MR. Analyzed the data: RN WR MHS MLS MR. Contributed reagents/materials/analysis tools: RN MJ ML MHS MLS WR AH BH KK VS DG MR. Wrote the paper: RN MJ ML MHS WR AH BH KK VS DG MR.","DG is a consultant for ViroPharma, Cubist, Merck, Cangene, Roche, Novartis, Summit, Daiichi Sankyo and Actelion. GOJO Industries, Inc. provided funding towards this study. Also, one of the authors (DG) holds patents relevant to the material presented in this study for the prevention of Clostridium difficile infection licensed to ViroPharma. The patents are as follows: 1. U.S. Patent and Trademark Office: Methods and Compositions for Prevention and Treatment of Clostridium difficile-Associated Diseases. Filed 9/15/95, PCT/US96/14868. Patent issued October 21, 2003, US Patent No. 6,635,260. 2. Canadian Intellectual Property Office: Methods and Compositions for Prevention and Treatment of Clostridium difficile-Associated Diseases. Patent issued December 10, 2002, Canadian Patent No. 2,232,001. 3. European Patent Office: Methods and Compositions for the Prevention and Treatment of Clostridium difficile-Associated Diseases. Patent issued November 11, 2005. Patent No. 0952773. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2016","03","Richard E Nelson","REN",12,TRUE,11,4,5,11,TRUE,TRUE,FALSE,0,NA,FALSE
